QRxPharma Limited develops and commercializes biopharmaceutical products primarily in Australia, the United States, and European markets. The company is developing pain management products, including Moxduo IR, an immediate release oral capsule for acute pain; Moxduo CR, a controlled release oral tablet for chronic pain; and Moxduo IV, an intravenous formulation for hospital-based pain. It also offers abuse prevention products comprising Stealth Beadlets, an abuse deterrent technology. QRxPharma Limited is based in Camberwell, Australia.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• No BuyIns.Net Alerts Available for QRXPY